Morsy, K.H. et al. 2016. Can eicosapentaenoic acid maintain the original ribavirin dose or affect the response during the treatment course of chronic hepatitis C virus (HCV) patients?. Turkish Journal of Gastroenterology. 27, 1 (Jan. 2016), 55–61. DOI:https://doi.org/10.5152/tjg.2015.150280.